Ignite Creation Date:
2025-12-25 @ 3:22 AM
Ignite Modification Date:
2026-01-05 @ 1:55 PM
Study NCT ID:
NCT04952805
Status:
UNKNOWN
Last Update Posted:
2022-02-03
First Post:
2021-07-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Select the Dose and Evaluate Safety and Efficacy of Monoclonal Antibody in Adult With Recently Diagnosed Asymptomatic to Moderately Severe COVID-19.
Sponsor:
Toscana Life Sciences Sviluppo s.r.l.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-06
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-08-31
Completion Date Type:
ESTIMATED
First Submit Date:
2021-07-01
First Submit QC Date:
None
Study First Post Date:
2021-07-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-02
Last Update Post Date:
2022-02-03
Last Update Post Date Type:
ACTUAL